Feedback / Questions
amiselimod (MT 1303) - Mitsubishi Tanabe, Bausch Health
Amiselimod: Initiation of P2 trial for ulcerative colitis in H1 2020
(Bausch Health)
-
Nov 5, 2019 -
Q3 2019 Reuslts
New P2 trial
https://ir.bauschhealth.com/~/media/Files/V/Valeant-IR/reports-and-presentations/20191104-3q19-bausch-health-earnings-presentation.pdf
Nov 5, 2019
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious